INDEMNIFICATION AGREEMENTIndemnification Agreement • January 9th, 2024 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations • New York
This Indemnification Agreement (this “Agreement”) is entered into as of [DATE] by and between Zhengye Biotechnology Holding Limited, a Cayman Islands company (the “Company”), and the undersigned, a director and/or an officer of the Company (“Indemnitee”), as applicable.
EMPLOYMENT AGREEMENTEmployment Agreement • January 9th, 2024 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
This EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of [ ], by and between Zhengye Biotechnology Holding Limited, a company incorporated and existing under the laws of Cayman Islands (the “Company”), and [ ], an individual (the “Executive”). The term “Company” as used herein with respect to all obligations of the Executive hereunder shall be deemed to include the Company and all of its direct or indirect parent companies, subsidiaries, affiliates, or subsidiaries or affiliates of its parent companies (collectively, the “Group”).
COOPERATION AGREEMENTCooperation Agreement • September 28th, 2023 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
WHEREAS, the Parties wish to collaborate on the research project named [The Development and Application of Fluorescent ERA Rapid Thermostatic Diagnostic Technology for Key Viral Diarrhea Diseases in Pigs].
COOPERATION AGREEMENTCooperation Agreement • September 28th, 2023 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
Health Commission of Jilin Province (or Jilin Provincial Institute of Public Health), hereinafter referred to as “Party B”, and
COOPERATION AGREEMENT OF JOINT RESEARCH PROJECTCooperation Agreement • September 28th, 2023 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
Jilin Agricultural University, a university located at 2888 Xincheng Street, Changchun City to host the research project, hereinafter referred to as “Party A”,
ZHENGYE BIOTECHNOLOGY HOLDING LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • August 22nd, 2024 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
The undersigned, Zhengye Biotechnology Holding Limited, an exempted company incorporated in the Cayman Islands (the “Company”), hereby confirms its agreement (this “Agreement”) with Kingswood Capital Partners, LLC, the representative of several underwriters as disclosed in Schedule A attached hereto (the “Representative,” and collectively with the several underwriters, the “Underwriters”) to issue and sell to the Underwriters an aggregate of 1,500,000 ordinary shares, par value US$0.000025 per share, of the Company (the “Firm Shares”). At the options of the Underwriters, the Company agrees, subject to the terms and conditions herein, to issue and sell to the Underwriters up to an aggregate of 225,000 ordinary shares, par value US$0.000025 per share, of the Company (the “Option Shares,” and collectively with the Firm Shares, the “Securities”). The offering and sale of Securities contemplated by this Agreement is referred to herein as the “Offering.”
MemorandumStrategic Cooperation Framework Agreement • September 28th, 2023 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
On September 9th, 2008, Shanghai Veterinary Research Institute of the Chinese Academy of Agricultural Sciences (hereinafter referred to as “Shanghai Veterinary Research Institute”) signed a strategic cooperation framework agreement with Jilin Zhengye Biological Products Co., Ltd (hereinafter referred to as “Zhengye Biological”), with a cooperation period of ten years. On March 1, 2011, the two sides signed a supplementary agreement on the basis of the strategic cooperation framework agreement. On September 9, 2018, the cooperation period between the two parties came to an end. Regarding how to end the cooperation and whether to continue the cooperation after the end of the cooperation, members of the new leadership team of Zhengye Biological and the main person in charge of the Shanghai Veterinary Research Institute negotiated on April 3, 2018 at the Shanghai Veterinary Research Institute.
COOPERATION AGREEMENTCooperation Agreement • September 28th, 2023 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
WHEREAS, the Parties wish to collaborate on the research project named [The Study of Rapid Visual Nucleic Acid Test of Various SARS-CoV-2 Mutants].
COOPERATION AGREEMENTCooperation Agreement • September 28th, 2023 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
WHEREAS, the Parties wish to collaborate on the research project named [Establishing the OFTu Immortalized Cell Line and its Application in Developing Ovine and Caprine Poxvirus Vaccine].
COOPERATION AGREEMENT OF JOINT RESEARCH PROJECTCooperation Agreement • September 28th, 2023 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
WHEREAS, the Parties wish to collaborate on the research project named [The Preparation Process Study of Immunoglobulin Y against Rotavirus Disease in Herbivorous Animals and its Prophylactic Application].
COOPERATION AGREEMENT OF JOINT RESEARCH PROJECTCooperation Agreement • September 28th, 2023 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
WHEREAS, the Parties wish to collaborate on the research project named [The Key Technique Study for the Development of the Live Gene-deletion-attenuated Vaccine against Ovine and Caprine Ecthyma (Orf)].
COOPERATION AGREEMENT OF JOINT RESEARCH PROJECTCooperation Agreement • September 28th, 2023 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
Jilin Agricultural University, a university located at No. 2888 Xincheng Street, Changchun City to host the research project, hereinafter referred to as “Party A”, and
COOPERATION AGREEMENTCooperation Agreement • September 28th, 2023 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
WHEREAS, the Parties wish to collaborate on the research project named [The Development and Efficacy Evaluation of the Porcine Hemagglutinating Encephalomyelitis Virus DNA Vaccine].
COOPERATION AGREEMENTCooperation Agreement • September 28th, 2023 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
Health Commission of Jilin Province (or Jilin Provincial Institute of Public Health), hereinafter referred to as “Party B”, and
COOPERATION AGREEMENT OF JOINT RESEARCH PROJECTCooperation Agreement • September 28th, 2023 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
WHEREAS, the Parties wish to collaborate on the research project named [The Development of Animal Microecological Vaccine for the Biological Control of African Swine Fever].
Jilin Zhengye Biological Products Co., Ltd DISTRIBUTION CONTRACT FOR VETERINARY VACCINES IN 2023Distribution Contract • January 9th, 2024 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
The parties are willing to leverage their strengths and work together to provide healthy breeding services. They will work together to develop and deliver value in the market of veterinary biological products, to unleash and meet the needs of customers, to improve production efficiency for customers, and to increase the penetration rates of their products. Party A should encourage and support Party B to pursue excellence and become a leader in the local market. Based on the principles of fairness, impartiality, mutual benefit, honesty, and trustworthiness, and in accordance with laws and regulations such as the Civil Code of the People’s Republic of China, the Regulations on the Administration of Veterinary Drugs, and the Measures for the Operation and Management of Veterinary Biological Products, the contract (hereinafter referred to as “the Contract”) is entered into between the parties concerned on the basis of equality and mutual benefit to develop business on terms and conditions
TECHNOLOGY LISENSING (TECHICAL SECRECTS) AGREEMENTTechnology Licensing Agreement • September 28th, 2023 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
TECHNOLOGY TRANSFER (TECHNICAL SECRECT) CONTRACTTechnology Transfer Contract • January 9th, 2024 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
TECHNOLOGY LISENSING (TECHICAL SECRECTS) AGREEMENTTechnology Licensing Agreement • September 28th, 2023 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
Project Name: Technology Transfer of the Swine Transmissible Gastroenteritis, Porcine Epidemic Diarrhea and Porcine Rotavirus (G5 type) Vaccine, live (Strain huadu+Strain CV777+Strain NX)
Agreement of Product Purchase and Sales Cooperation FrameworkProduct Purchase and Sales Cooperation Framework • May 15th, 2024 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
Based on the principles of fairness, impartiality, mutual benefit, honesty, and trustworthiness, the agreement (hereinafter referred to as “the Agreement”) is entered into between Party A and Party B on terms and conditions mutually agreed upon as follows.
COOPERATION AGREEMENTCooperation Agreement • September 28th, 2023 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
WHEREAS, the Parties wish to collaborate on the research project named [The Development of Ovine and Caprine Contagious Pustular Virus mRNA Vaccine Based on Lipid Nanoparticle Technology].
TECHNOLOGY DEVELOPMENT (COOPERATION) CONTRACTTechnology Development Contract • January 9th, 2024 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
General Contract for Veterinary Vaccines SalesGeneral Contract for Veterinary Vaccines Sales • May 15th, 2024 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
NOW, THEREFORE, on the basis of equality, mutual assent and good faith, in accordance with relevant laws, regulations and regulatory legal documents such as the Civil Code of the People’s Republic of China, the Parties have reached this contract (hereinafter referred to as “the Contract”) through friendly negotiations.
COOPERATION AGREEMENT OF JOINT RESEARCH PROJECTCooperation Agreement • September 28th, 2023 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
Jilin Agricultural Science and Technology University, a university located at No. 77 Hanlin Road, Economic and Technological Development Zone, Jilin City to host the research project with the project contact person Yin Baishuang whose phone number is 15144254601, hereinafter referred to as “Party A”, and
